Literature DB >> 7558152

Different migration patterns of antigen-presenting cells correlate with Th1/Th2-type responses in mice.

Y Morikawa1, K Tohya, H Ishida, N Matsuura, K Kakudo.   

Abstract

Antibodies are produced when antigen-presenting cells (APC) pulsed with an antigen are injected intravenously (i.v.) into BALB/c mice, but subcutaneous (s.c.) injection of such APC causes delayed-type hypersensitivity (DTH). To identify the anatomic sites where T and B cells are activated, we labelled splenic dendritic cells (DC) with a fluorochrome, PKH 26, injected them i.v. or s.c., and used the label to locate them. When the DC were injected i.v., germinal centres in the spleen were hyperplastic on day 1. Most DC moved to T-dependent areas of the white and red pulp on day 1 and remained there at least until day 5, but no DC migrated into the lymph nodes. When the DC were injected s.c., they were in the sinus on day 1 and had entered T-dependent area of draining lymph nodes only by day 3; hyperplasia of germinal centres in the spleen and migration of DC into the spleen were not found. We used the polymerase chain reaction (PCR) to study which mice had spleen cells and lymph node cells that produced the cytokines interleukin (IL)-2, IL-4, IL-10, and interferon-gamma (IFN-gamma). In the sensitization phase, day 1 after DC injection i.v., almost all IL-10 transcript was found in spleen cells, but after DC injection s.c., IL-2 message was most abundant in lymph node cells. The expression of mRNA for IL-4 and IFN-gamma in mice that received DC i.v. was not different from that in mice that received DC s.c. in this phase. Immunohistochemical staining showed that cells stained for IL-10 were in the T-dependent area of the spleen from mice that received DC i.v. 1 day after the injection. Three days after the injection of DC i.v., cells stained for IL-10 were in the germinal centres as well. The number of such cells in the spleen of mice that received DC i.v. was significantly more than that in mice that received DC s.c. IL-10 may be important in development of TH2 response.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7558152      PMCID: PMC1383786     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  36 in total

1.  First-strand cDNA synthesis primed with oligo(dT).

Authors:  M S Krug; S L Berger
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

2.  The role of antigen-presenting cells in the regulation of delayed-type hypersensitivity. II. Epidermal Langerhans' cells and peritoneal exudate macrophages.

Authors:  Y Morikawa; M Furotani; N Matsuura; K Kakudo
Journal:  Cell Immunol       Date:  1993-11       Impact factor: 4.868

3.  Role of IL-10 on antigen-presenting cell function for schistosomal egg-specific monoclonal T helper cell responses in vitro and in vivo.

Authors:  P O Flores Villanueva; S M Chikunguwo; T S Harris; M J Stadecker
Journal:  J Immunol       Date:  1993-09-15       Impact factor: 5.422

4.  Demonstration of T15 idiotype-positive effector and suppressor T cells for phosphorylcholine-specific delayed-type hypersensitivity response in CBA/N or (CBA/N X BALB/c)F1 male mice.

Authors:  K Sugimura; T Kishimoto; K Maeda; Y Yamamura
Journal:  Eur J Immunol       Date:  1981-06       Impact factor: 5.532

5.  The relationship between humoral and cell-mediated immunity.

Authors:  C R Parish
Journal:  Transplant Rev       Date:  1972

6.  Mechanisms of regulation of cell-mediated immune responses. I. Effect of the route of immunization with TNP-coupled syngeneic cells on the induction and suppression of contact sensitivity to picryl chloride.

Authors:  M I Greene; M Sugimoto; B Benacerraf
Journal:  J Immunol       Date:  1978-05       Impact factor: 5.422

7.  Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins.

Authors:  T R Mosmann; H Cherwinski; M W Bond; M A Giedlin; R L Coffman
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

8.  Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones.

Authors:  D J Cher; T R Mosmann
Journal:  J Immunol       Date:  1987-06-01       Impact factor: 5.422

9.  Cloned, Ia-restricted T cells that do not produce interleukin 4(IL 4)/B cell stimulatory factor 1(BSF-1) fail to help antigen-specific B cells.

Authors:  L Killar; G MacDonald; J West; A Woods; K Bottomly
Journal:  J Immunol       Date:  1987-03-15       Impact factor: 5.422

10.  Cell-mediated and humoral immune responses in mice. III. Dynamic balance between delayed-type hypersensitivity and antibody response.

Authors:  Y Katsura
Journal:  Immunology       Date:  1977-03       Impact factor: 7.397

View more
  13 in total

1.  Low-grade B cell lymphomas of mucosa-associated lymphoid tissue (MALT-type) require CD40-mediated signaling and Th2-type cytokines for in vitro growth and differentiation.

Authors:  A Greiner; C Knörr; Y Qin; W Sebald; A Schimpl; J Banchereau; H K Müller-Hermelink
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

Review 2.  Dendritic cells, T cell tolerance and therapy of adverse immune reactions.

Authors:  P A Morel; M Feili-Hariri; P T Coates; A W Thomson
Journal:  Clin Exp Immunol       Date:  2003-07       Impact factor: 4.330

3.  Interleukin-7 in the skin of Schistosoma mansoni-infected mice is associated with a decrease in interferon-gamma production and leads to an aggravation of the disease.

Authors:  I Wolowczuk; M Delacre; O Roye; S L Giannini; C Auriault
Journal:  Immunology       Date:  1997-05       Impact factor: 7.397

4.  Cytokine production by CD4 and CD8 T cells during the growth of Mycobacterium tuberculosis in mice.

Authors:  A D Howard; B S Zwilling
Journal:  Clin Exp Immunol       Date:  1998-09       Impact factor: 4.330

Review 5.  Immune recognition and rejection of allogeneic skin grafts.

Authors:  Gilles Benichou; Yohei Yamada; Seok-Hyun Yun; Charles Lin; Michael Fray; Georges Tocco
Journal:  Immunotherapy       Date:  2011-06       Impact factor: 4.196

6.  Cryoimmunologic antitumor effects enhanced by dendritic cells in osteosarcoma.

Authors:  Masanori Kawano; Hideji Nishida; Yasunari Nakamoto; Hiroshi Tsumura; Hiroyuki Tsuchiya
Journal:  Clin Orthop Relat Res       Date:  2010-03-16       Impact factor: 4.176

7.  Dendritic cells route human immunodeficiency virus to lymph nodes after vaginal or intravenous administration to mice.

Authors:  C Masurier; B Salomon; N Guettari; C Pioche; F Lachapelle; M Guigon; D Klatzmann
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

8.  Interactions of dendritic cells with fibronectin and endothelial cells.

Authors:  C Jancic; H E Chuluyan; A Morelli; A Larregina; E Kolkowski; M Saracco; M Barboza; W S Leiva; L Fainboim
Journal:  Immunology       Date:  1998-10       Impact factor: 7.397

9.  Protective mucosal Th2 immune response against Toxoplasma gondii by murine mesenteric lymph node dendritic cells.

Authors:  Isabelle Dimier-Poisson; Fleur Aline; Marie-Noëlle Mévélec; Céline Beauvillain; Dominique Buzoni-Gatel; Daniel Bout
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

Review 10.  Current immunotherapeutic strategies for central nervous system tumors.

Authors:  Medina C Kushen; Adam M Sonabend; Maciej S Lesniak
Journal:  Surg Oncol Clin N Am       Date:  2007-10       Impact factor: 3.495

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.